INTRODUCTION
Due to the advent of monoclonal antibody agents in the treatment of metastatic melanoma, patients with this disease are surviving longer [1] . Early recognition of the disease has therefore become even more important. We present a patient with vitelliform maculopathy, a paraneoplastic retinal maculopathy that is under-recognized.
Clinically the retinal findings of serous detachments and macular pigmentary changes are remarkable, while at the same time these patients have surprisingly very few symptoms. This is in contrast to patients who develop Informed consent was obtained from all patients for being included in the study.
CASE REPORT
A 65-year-old male being worked up for metastatic disease was found to have multiple exudative vitelliform lesions in both maculae (Figs. 1, 3 ). These lesions are found in patients with metastatic melanoma. Biopsy of an occipital lesion confirmed melanoma (Fig. 5a ).
A positron emission tomography (PET) scan also showed lesions in the lung, axilla and gallbladder ( Fig. 5b) (Figs. 6, 7) . Fundus autofluorescence imaging delineates the linear yellowish lipofuscinoid deposits and areas of old detachment, and small areas of pigment epithelial atrophy (Fig. 8) .
DISCUSSION
In the 1990s the 5-year survival rate of stage 4 melanoma to the brain was less than 4%, until the advent of new therapies including The retinopathy of EPVM is a paraneoplastic process, as seen in MAR, but without vascular narrowing or optic atrophy. The lesions are primarily in the maculae, and can have a similar look to the vitelliform changes seen in Best's Disease [6] , in which patients have a vitelliform ''yolk-like'' lesion associated with a serous detachment in the macula [7, 8] accumulation or discoloration; the serous detachment is secondary to choroidal vascular hyperpermeability [10] [11] [12] . In contrast to EPVM, there is also usually only one symptomatic large serous detachment centered on the macula without significant pigmentary changes, and only one eye is typically affected at a time. OCT is very useful in differentiating these three conditions.
Testing by OCT is quicker and easier for these patients, who are suddenly encompassed in care, compared to previous testing with fluorescein angiogram which required an injection. When fluorescein angiography is performed in patients with EPVM, it demonstrates some mild staining of the lesions with no leakage typically. In Best's Disease and CSR obvious hyperfluorescence and leakage is typically noted.
Fig. 8 Fundus autofluorescence depicting areas of hyperautofluorescence corresponding to areas of disease and detachment in both eyes
In MAR where symptoms of flickering, shimmering and photopsias occur [13] [14] [15] [16] , patients with EPVM often do not present with these symptoms or any reduction of vision [17, 18] . The patient reported here did not complain of such symptoms, or of any blurring of vision.
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